Page last updated: 2024-10-22

albendazole and Infections, Microspora

albendazole has been researched along with Infections, Microspora in 60 studies

Research Excerpts

ExcerptRelevanceReference
"Albendazole therapy was effective in improving the clinical manifestations and decreasing the duration of the illness of children with diarrhea caused by Microsporidium."9.11Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children. ( Avila-Aguero, ML; Canas-Coto, A; Faingezicht, I; París, MM; Tremoulet, AH; Ulloa-Gutierrez, R, 2004)
"The treatment with albendazole (10 days) followed by fenbendazole (5 days) proved to be effective and safe after diagnosis."5.72Successful use of albendazole and fenbendazole therapy in a cat with persistent diarrhea due Enterocytozoon bieneusi. ( Coutinho, SD; DE Araújo, RS; Lallo, MA; Romano, F; Xavier, JG, 2022)
"Albendazole therapy was effective in improving the clinical manifestations and decreasing the duration of the illness of children with diarrhea caused by Microsporidium."5.11Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children. ( Avila-Aguero, ML; Canas-Coto, A; Faingezicht, I; París, MM; Tremoulet, AH; Ulloa-Gutierrez, R, 2004)
"To describe an immunocompetent male with bilateral microsporidial keratoconjunctivitis who responded to treatment with albendazole, propamidine, and fumagillin."4.82Bilateral microsporidial keratoconjunctivitis in an immunocompetent non-contact lens wearer. ( Coroneo, MT; Francis, IC; Hawkins, GS; Lewis, NL, 2003)
" While undergoing treatment with albendazole, he developed worsening diarrhea with abdominal pain and fever."4.79Albendazole-induced pseudomembranous colitis. ( Altice, FL; Marino, C; Shah, V, 1996)
" The symptoms of ocular discomfort and clinical signs of keratoconjunctivitis resolved after 2 months of treatment with albendazole and topical fumagillin."3.71Microsporidial keratoconjunctivitis in a healthy contact lens wearer without human immunodeficiency virus infection. ( Chan, C; Ling, ML; Tan, D; Theng, J, 2001)
" The signs and symptoms of the bilateral keratoconjunctivitis resolved after treatment with albendazole."3.69Microsporidial keratoconjunctivitis in a patient without human immunodeficiency virus infection. ( Cevallos, V; Cunningham, ET; Margolis, TP; Silverstein, BE; Wong, IG, 1997)
"Fumagillin has a broader anti-microsporidian activity than albendazole and is active against both Ent."2.58Therapeutic targets for the treatment of microsporidiosis in humans. ( Han, B; Weiss, LM, 2018)
"Albendazole has changed from being a drug for individuals with worms to one to treat communities and provide benefit in public health terms."2.41Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations. ( Horton, J, 2002)
"Microsporidiosis is recognized as an increasingly important infection, particularly in patients with human immunodeficiency virus (HIV) infection."2.40Microsporidial disease in HIV-infected patients: a report of 42 patients and review of the literature. ( Crowe, SM; Leder, K; Ryan, N; Spelman, D, 1998)
"Treatment with albendazole led to clinical responses in six of 10 patients, and dietary manipulation resulted in clinical improvement in eight of nine patients."2.39Clinical features of microsporidiosis in patients with AIDS. ( Asmuth, DM; DeGirolami, PC; Desai, G; Ezratty, CR; Federman, M; Pleskow, DK; Wanke, CA, 1994)
"Stromal microsporidiosis is recalcitrant and very often requires therapeutic keratoplasty for effective eradication."1.72A case of stromal microsporidiosis: medical strategies employed for successful resolution. ( Raghavan, A; Raja, DR; Rammohan, R; Venkatapathy, N, 2022)
"The treatment with albendazole (10 days) followed by fenbendazole (5 days) proved to be effective and safe after diagnosis."1.72Successful use of albendazole and fenbendazole therapy in a cat with persistent diarrhea due Enterocytozoon bieneusi. ( Coutinho, SD; DE Araújo, RS; Lallo, MA; Romano, F; Xavier, JG, 2022)
"She was diagnosed with disseminated microsporidiosis."1.62Case Report: First Report of Disseminated Trachipleistophora hominis Infection in an AIDS Patient from Thailand. ( Brownell, N; Hortiwakul, T; Kongdachalert, S; Phumee, A; Seatamanoch, N; Siripaitoon, P; Siriyasatien, P, 2021)
"Microsporidiosis is a rare, but emerging opportunistic infection in solid organ transplant and stem cell transplant recipients."1.56Renal Microsporidiosis in Pediatric Bone Marrow Transplant Recipients: A Case Series. ( Annigeri, RA; Jacob, SS; Kumar, S; Mahesh, R; Mani, R; Parameswaran, A; Shah, S; Uppuluri, R, 2020)
"We recommend that microsporidiosis be considered in the differential diagnosis of pyrexia of unknown origin in severely immunocompromised pediatric solid organ transplant recipients, particularly when associated with diarrhea."1.40Microsporidiosis in pediatric renal transplant patients in Cape Town, South Africa: two case reports. ( Birkhead, M; Frean, J; Gajjar, P; Ladapo, TA; Nourse, P; Pillay, K; Poonsamy, B, 2014)
"To report a case of stromal microsporidiosis that responded to medical treatment with systemic albendazole and topical chlorhexidine."1.37Microsporidial stromal keratitis successfully treated with medical therapy: a case report. ( Garg, P; Murthy, SI; Sangit, VA, 2011)
"This case of microsporidiosis manifested as mutiple intracranial lesions separated in space and time, and neurological and radiological findings were improved with albendazole administration."1.35[Multiple intracerebral enhanced lesions strongly suspected to be microsporidiosis. A case report]. ( Kanamori, M; Kumabe, T; Okuyama, H; Tominaga, T; Watanabe, M, 2008)
"Stromal microsporidiosis was confirmed after corneal biopsy."1.34Microsporidium stromal keratitis: in vivo confocal findings. ( Bonshek, RE; Curry, A; Hau, S; Irion, LD; Mehta, JS; Sagoo, MS; Tuft, SJ, 2007)
"It was concluded that the microsporidiosis was a pre-existing opportunistic infection, whose presence was unmasked by a form of immune restoration induced by HAART."1.31Microsporidial keratoconjunctivitis after HAART. ( Gajdatsy, AD; Tay-Kearney, ML, 2001)
"Multiorgan microsporidiosis due to Enterocytozoon bieneusi was diagnosed in an HIV-infected patient."1.30Enterocytozoon bieneusi multiorgan microsporidiosis in a HIV-infected patient. ( Allamagny, E; Amiel, C; Canton, P; Georges, E; Guedenet, JC; Kurès, L; May, T; Rabaud, C, 1998)
"Disseminated microsporidiosis due to the newly described species Septata intestinalis in nine patients infected with human immunodeficiency virus is described."1.29Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole. ( Dore, GJ; Field, AS; Harkness, JL; Hing, MC; Marriott, DJ, 1995)
"Treatment with albendazole and paromomycin did not affect the spore shedding in three patients with E bieneusi infection."1.29Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique. ( Bartelsman, JF; Bruins, JJ; Canning, EU; Dankert, J; Eeftinck Schattenkerk, JK; Reiss, P; Snijders, F; van den Bergh Weerman, MA; van Gool, T, 1993)
"Microsporidiosis is a common finding in HIV-infected patients who have diarrhoea."1.29Intestinal microsporidiosis with Septata intestinalis in a patient with AIDS--response to albendazole. ( Diehl, V; Fätkenheuer, G; Franzen, C; Mahrle, G; Müller, A; Salzberger, B; Schrappe, M; Schwenk, A, 1995)
" There are some dosage limitations, but the manufacturer says these limitations can be easily resolved."1.29Don't get caught with your pants down. ( Learned, J, 1996)
"Six consecutive AIDS patients with small intestinal microsporidiosis as the only identified cause of diarrhoea after intensive gastrointestinal investigations."1.28Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. ( Blanshard, C; Dowell, S; Ellis, DS; Gazzard, BG; Tovey, DG, 1992)

Research

Studies (60)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's28 (46.67)18.2507
2000's20 (33.33)29.6817
2010's8 (13.33)24.3611
2020's4 (6.67)2.80

Authors

AuthorsStudies
Siripaitoon, P1
Seatamanoch, N1
Brownell, N1
Kongdachalert, S1
Hortiwakul, T1
Phumee, A1
Siriyasatien, P1
Raghavan, A1
Raja, DR1
Venkatapathy, N1
Rammohan, R1
Romano, F1
Xavier, JG1
DE Araújo, RS1
Coutinho, SD1
Lallo, MA1
Connors, WJ1
Carson, JA1
Chan, WW1
Parkins, MD1
Brown, M1
Longano, A1
Dendle, C1
Polkinghorne, KR1
Kanellis, J1
Shah, S1
Jacob, SS1
Mani, R1
Parameswaran, A1
Kumar, S1
Annigeri, RA1
Mahesh, R1
Uppuluri, R1
García-Torres, I1
De la Mora-De la Mora, I1
Hernández-Alcántara, G1
Molina-Ortiz, D1
Caballero-Salazar, S1
Olivos-García, A1
Nava, G1
López-Velázquez, G1
Enríquez-Flores, S1
Kicia, M1
Sędzimirska, M1
Sak, B1
Kváč, M1
Wesołowska, M1
Hendrich, AB1
Kopacz, Ż1
Han, B1
Weiss, LM2
Ladapo, TA1
Nourse, P1
Pillay, K1
Frean, J1
Birkhead, M1
Poonsamy, B1
Gajjar, P1
Okuyama, H1
Kanamori, M1
Watanabe, M1
Kumabe, T1
Tominaga, T1
Usluca, S1
Aksoy, U1
Sangit, VA1
Murthy, SI1
Garg, P1
Almeida, MA1
Geden, CJ1
Boohene, CK1
Becnel, JJ1
Prado, AP1
Moon, SJ1
Mann, PM1
Matoba, AY1
Lewis, NL1
Francis, IC1
Hawkins, GS1
Coroneo, MT1
Gross, U1
Horton, J1
Chan, CM1
Theng, JT1
Li, L1
Tan, DT1
Coyle, CM1
Rhodes, LV1
Cali, A1
Takvorian, PM1
Brown, DF1
Visvesvara, GS2
Xiao, L1
Naktin, J1
Young, E1
Gareca, M1
Colasante, G1
Wittner, M1
Tremoulet, AH1
Avila-Aguero, ML1
París, MM1
Canas-Coto, A1
Ulloa-Gutierrez, R1
Faingezicht, I1
Fogla, R1
Padmanabhan, P1
Therese, KL1
Biswas, J1
Madhavan, HN1
Wichro, E1
Hoelzl, D1
Krause, R1
Bertha, G1
Reinthaler, F1
Wenisch, C1
Pariyakanok, L1
Jongwutiwes, S1
Sagoo, MS1
Mehta, JS1
Hau, S1
Irion, LD1
Curry, A2
Bonshek, RE1
Tuft, SJ1
Gunnarsson, G1
Hurlbut, D1
DeGirolami, PC3
Federman, M3
Wanke, C2
Dore, GJ1
Marriott, DJ2
Hing, MC1
Harkness, JL2
Field, AS2
Molina, JM1
Oksenhendler, E1
Beauvais, B1
Sarfati, C1
Jaccard, A1
Derouin, F1
Modaï, J1
Oldfield, EC1
Asmuth, DM1
Ezratty, CR1
Pleskow, DK1
Desai, G1
Wanke, CA2
Weber, R1
Sauer, B1
Spycher, MA1
Deplazes, P1
Keller, R1
Ammann, R1
Briner, J1
Lüthy, R1
Blanshard, C2
Ellis, DS2
Dowell, SP1
Tovey, G1
Gazzard, BG2
Dieterich, DT1
Lew, EA1
Kotler, DP1
Poles, MA1
Orenstein, JM1
Canning, EU3
Di Candilo, E1
Bassotti, G1
Marroni, M1
Baldelli, F1
Morelli, A1
van Gool, T1
Snijders, F1
Reiss, P1
Eeftinck Schattenkerk, JK1
van den Bergh Weerman, MA1
Bartelsman, JF1
Bruins, JJ1
Dankert, J1
Svenson, J1
MacLean, JD1
Kokoskin-Nelson, E1
Szabo, J1
Lough, J1
Gill, MJ1
Franzen, C2
Müller, A1
Schwenk, A1
Salzberger, B1
Fätkenheuer, G1
Mahrle, G1
Diehl, V1
Schrappe, M1
Shah, V1
Marino, C1
Altice, FL1
Rossi, RM1
Milliken, ST1
Brew, BJ1
Kench, JG1
Darveniza, P1
Dunand, VA1
Hammer, SM1
Rossi, R1
Poulin, M1
Albrecht, MA1
Doweiko, JP1
Coakley, E1
Piessens, E1
Silverstein, BE1
Cunningham, ET1
Margolis, TP1
Cevallos, V1
Wong, IG1
Schmahl, G1
Benini, J1
Georges, E2
Rabaud, C2
Amiel, C1
Kurès, L1
Guedenet, JC2
Allamagny, E2
May, T2
Canton, P2
Leder, K1
Ryan, N1
Spelman, D1
Crowe, SM1
Dionisio, D1
Manneschi, LI1
Di Lollo, S1
Orsi, A1
Sterrantino, G1
Leoncini, F1
Pozzi, M1
Vinattieri, MA1
Tani, A1
Papucci, A1
Speare, DJ1
Athanassopoulou, F1
Daley, J1
Sanchez, JG1
von Gottberg, AM1
Dini, LA1
Frean, JA1
Grimwood, AJ1
Goetz, M1
Eichenlaub, S1
Pape, GR1
Hoffmann, RM1
Theng, J1
Chan, C1
Ling, ML1
Tan, D1
Learned, J1
Weitzel, T1
Wolff, M1
Dabanch, J1
Levy, I1
Schmetz, C1
Sobottka, I1
Gajdatsy, AD1
Tay-Kearney, ML1
Yoken, J1
Forbes, B1
Maguire, AM1
Prenner, JL1
Carpentieri, D1
Mietz, H1
Hoppe, T1
Bartz-Schmidt, KU1
Tovey, DG1
Dowell, S1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single Dose Treatment With Diethylcarbamazine, Albendazole and Ivermectin in Humans With and Without Wuchereria Bancrofti Infection in Côte d'Ivoire[NCT02845713]Phase 166 participants (Actual)Interventional2016-04-17Completed
Comparison of Ivermectin Alone With Albendazole (ALB) Plus Ivermectin (IVM) in Their Efficacy Against Onchocerciasis[NCT03238131]Phase 3272 participants (Actual)Interventional2012-04-30Completed
Alternative Chemotherapies for Lymphatic Filariasis (LF) Treatment and Elimination in Africa [Cote d'Ivoire][NCT02974049]189 participants (Actual)Interventional2015-01-31Completed
A Clinical Trial to Assess the Safety and Efficacy of Moxidectin Combination Treatments vs. Ivermectin Combination Treatments for Bancroftian Filariasis[NCT04410406]Phase 3164 participants (Actual)Interventional2020-08-20Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

11 reviews available for albendazole and Infections, Microspora

ArticleYear
Confirmed microsporidial graft infection in a HIV-negative renal transplant recipient: A case report and review of the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:3

    Topics: Adolescent; Adult; Albendazole; Antifungal Agents; Biopsy; Female; HIV Infections; Humans; Kidney; K

2018
Therapeutic targets for the treatment of microsporidiosis in humans.
    Expert opinion on therapeutic targets, 2018, Volume: 22, Issue:11

    Topics: Albendazole; Animals; Antifungal Agents; Cyclohexanes; Drug Design; Fatty Acids, Unsaturated; Humans

2018
Bilateral microsporidial keratoconjunctivitis in an immunocompetent non-contact lens wearer.
    Cornea, 2003, Volume: 22, Issue:4

    Topics: Adult; Albendazole; Animals; Antiprotozoal Agents; Benzamidines; Contact Lenses; Cyclohexanes; Fatty

2003
Treatment of microsporidiosis including albendazole.
    Parasitology research, 2003, Volume: 90 Supp 1

    Topics: Albendazole; Animals; Antiprotozoal Agents; Apansporoblastina; Humans; Microsporidiosis

2003
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel

2002
Multiorgan microsporidiosis: report of five cases and review.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Biliary Tract Dis

1995
Clinical features of microsporidiosis in patients with AIDS.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:5

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Boston; CD4-Positive T-Lymphocyt

1994
Human microsporidiosis.
    The Journal of infection, 1993, Volume: 27, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Albendazole; Animals; Eye Infections, Parasitic; Humans; Inte

1993
Albendazole-induced pseudomembranous colitis.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:7

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Anthelmintics; Chronic Disease; Diarrhea;

1996
Parasitic sinusitis and otitis in patients infected with human immunodeficiency virus: report of five cases and review.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Amebiasis; Animals; Anthelmintics; Anti-B

1997
Microsporidial disease in HIV-infected patients: a report of 42 patients and review of the literature.
    Scandinavian journal of infectious diseases, 1998, Volume: 30, Issue:4

    Topics: Adult; Aged; Albendazole; Animals; Anti-Infective Agents; Antiprotozoal Agents; Apansporoblastina; E

1998

Trials

3 trials available for albendazole and Infections, Microspora

ArticleYear
Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children.
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:10

    Topics: Albendazole; Animals; Antiprotozoal Agents; Child, Preschool; Costa Rica; Diarrhea; Female; Humans;

2004
Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS.
    The Journal of infectious diseases, 1994, Volume: 169, Issue:1

    Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Albendazole; Chronic Disease; Di

1994
Microsporidiosis.
    Treatment review, 1995, Issue:no 18

    Topics: AIDS-Related Opportunistic Infections; Albendazole; Anthelmintics; Double-Blind Method; Humans; Micr

1995

Other Studies

46 other studies available for albendazole and Infections, Microspora

ArticleYear
Case Report: First Report of Disseminated Trachipleistophora hominis Infection in an AIDS Patient from Thailand.
    The American journal of tropical medicine and hygiene, 2021, 08-30, Volume: 105, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Albendazole; Clind

2021
A case of stromal microsporidiosis: medical strategies employed for successful resolution.
    BMJ case reports, 2022, Feb-14, Volume: 15, Issue:2

    Topics: Albendazole; Chlorhexidine; Eye Infections, Fungal; Humans; Microsporidiosis

2022
Successful use of albendazole and fenbendazole therapy in a cat with persistent diarrhea due Enterocytozoon bieneusi.
    The Journal of veterinary medical science, 2022, Jun-18, Volume: 84, Issue:6

    Topics: Albendazole; Animals; Cat Diseases; Cats; Diarrhea; Enterocytozoon; Feces; Fenbendazole; Genotype; M

2022
Albendazole-responsive disseminated Tubulinosema acridophagus in a patient with chronic lymphocytic leukaemia.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017, Volume: 23, Issue:9

    Topics: Albendazole; Anti-Infective Agents; Female; Histocytochemistry; Humans; Leukemia, Lymphocytic, Chron

2017
Renal Microsporidiosis in Pediatric Bone Marrow Transplant Recipients: A Case Series.
    Turk patoloji dergisi, 2020, Volume: 36, Issue:1

    Topics: Acute Kidney Injury; Adolescent; Albendazole; Antiparasitic Agents; Bone Marrow Transplantation; Fat

2020
First characterization of a microsporidial triosephosphate isomerase and the biochemical mechanisms of its inactivation to propose a new druggable target.
    Scientific reports, 2018, 06-05, Volume: 8, Issue:1

    Topics: Albendazole; Amino Acid Sequence; Encephalitozoon; Fungal Proteins; Gastrointestinal Diseases; Gene

2018
Respiratory microsporidiosis caused by Enterocytozoon bieneusi in an HIV-negative hematopoietic stem cell transplant recipient.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 77

    Topics: Albendazole; Bronchoalveolar Lavage; Enterocytozoon; Female; Hematopoietic Stem Cell Transplantation

2018
Microsporidiosis in pediatric renal transplant patients in Cape Town, South Africa: two case reports.
    Pediatric transplantation, 2014, Volume: 18, Issue:7

    Topics: Adolescent; Albendazole; Cytomegalovirus Infections; Diarrhea; Encephalitozoon cuniculi; Female; Fev

2014
[Multiple intracerebral enhanced lesions strongly suspected to be microsporidiosis. A case report].
    No shinkei geka. Neurological surgery, 2008, Volume: 36, Issue:7

    Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Humans; Male; Microsporidiosis

2008
[Microsporidium spp. infection in an immunocompromised child diagnosed by polymerase chain reaction].
    Mikrobiyoloji bulteni, 2010, Volume: 44, Issue:4

    Topics: Albendazole; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Diarrhea; Drug Therapy, Combina

2010
Microsporidial stromal keratitis successfully treated with medical therapy: a case report.
    Cornea, 2011, Volume: 30, Issue:11

    Topics: Administration, Oral; Administration, Topical; Adolescent; Albendazole; Antifungal Agents; Chlorhexi

2011
Microsporidiosis of Tachinaephagus zealandicus Ashmead (Hymenoptera: Encyrtidae).
    Memorias do Instituto Oswaldo Cruz, 2002, Volume: 97, Issue:4

    Topics: Albendazole; Animals; Antiprotozoal Agents; Female; Infectious Disease Transmission, Vertical; Micro

2002
Microsporidial keratoconjunctivitis in a healthy patient with a history of LASIK surgery.
    Cornea, 2003, Volume: 22, Issue:3

    Topics: Albendazole; Animals; Antiprotozoal Agents; Cornea; Cyclohexanes; Drug Therapy, Combination; Eye Inf

2003
Microsporidial keratoconjunctivitis in healthy individuals: a case series.
    Ophthalmology, 2003, Volume: 110, Issue:7

    Topics: Adolescent; Adult; Albendazole; Antiprotozoal Agents; Chloramphenicol; Cornea; Cyclohexanes; Drug Th

2003
Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen.
    The New England journal of medicine, 2004, Jul-01, Volume: 351, Issue:1

    Topics: Albendazole; Animals; Antibodies, Monoclonal; Antiprotozoal Agents; Antirheumatic Agents; Apansporob

2004
Chronic microsporidial stromal keratitis in an immunocompetent, non-contact lens wearer.
    Indian journal of ophthalmology, 2005, Volume: 53, Issue:2

    Topics: Aged; Aged, 80 and over; Albendazole; Animals; Antiprotozoal Agents; Benzamidines; Chronic Disease;

2005
Microsporidiosis in travel-associated chronic diarrhea in immune-competent patients.
    The American journal of tropical medicine and hygiene, 2005, Volume: 73, Issue:2

    Topics: Adolescent; Adult; Albendazole; Animals; Antiprotozoal Agents; Chronic Disease; Diarrhea; Encephalit

2005
Keratitis caused by Trachipleistophora anthropopthera.
    The Journal of infection, 2005, Volume: 51, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Anti-Infective Agents; Cornea; Cyclohexan

2005
Microsporidium stromal keratitis: in vivo confocal findings.
    Cornea, 2007, Volume: 26, Issue:7

    Topics: Aged; Albendazole; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Cyclohexanes; Drug Therapy, Com

2007
Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Duodenum; Feces;

1995
Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: clinical features and response to albendazole therapy.
    The Journal of infectious diseases, 1995, Volume: 171, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Diarrhea; Duodenum; Feces; Human

1995
Albendazole: new hope for treatment of microsporidiosis in AIDS.
    The American journal of gastroenterology, 1995, Volume: 90, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Albendazole; Animals; Diarrhea; Humans; Intestinal Diseases,

1995
Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 19, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Chronic Disease; Feces; Humans;

1994
Electron microscopic changes in Enterocytozoon bieneusi following treatment with albendazole.
    Journal of clinical pathology, 1993, Volume: 46, Issue:10

    Topics: Albendazole; Animals; Diarrhea; Humans; Intestinal Diseases, Parasitic; Microscopy, Electron; Micros

1993
Enterocytozoon bieneusi detection in a patient with human immunodeficiency virus infection and chronic diarrhoea: response to albendazole treatment.
    The Italian journal of gastroenterology, 1993, Volume: 25, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Biopsy; Chronic Disease; Diarrhe

1993
Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique.
    Journal of clinical pathology, 1993, Volume: 46, Issue:8

    Topics: Albendazole; Animals; Encephalitozoon; Feces; Fluorescent Antibody Technique; Fluorescent Dyes; HIV

1993
Microsporidiosis in AIDS patients.
    Canada communicable disease report = Releve des maladies transmissibles au Canada, 1993, Jan-30, Volume: 19, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Feces; Humans; Intestinal Diseases, Paras

1993
Intestinal microsporidiosis with Septata intestinalis in a patient with AIDS--response to albendazole.
    The Journal of infection, 1995, Volume: 31, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Albendazole; Anima

1995
Microsporidian sinusitis in patients with the acquired immunodeficiency syndrome.
    The Laryngoscope, 1996, Volume: 106, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Albendazole; Animals; Antiprotozoal Agents; Humans; Male;

1996
Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS.
    Journal of clinical microbiology, 1996, Volume: 34, Issue:11

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anti-Infective Agents; Drug Ther

1996
Microsporidial keratoconjunctivitis in a patient without human immunodeficiency virus infection.
    American journal of ophthalmology, 1997, Volume: 124, Issue:3

    Topics: Adult; Albendazole; Animals; Anthelmintics; Epithelium, Corneal; Eye Infections, Parasitic; Female;

1997
Treatment of fish parasites. 11. Effects of different benzimidazole derivatives (albendazole, mebendazole, fenbendazole) on Glugea anomala, Moniez, 1887 (Microsporidia): ultrastructural aspects and efficacy studies.
    Parasitology research, 1998, Volume: 84, Issue:1

    Topics: Albendazole; Animals; Antiprotozoal Agents; Benzimidazoles; Fenbendazole; Fish Diseases; Fishes; Meb

1998
Enterocytozoon bieneusi multiorgan microsporidiosis in a HIV-infected patient.
    The Journal of infection, 1998, Volume: 36, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Antiprotozoal Agents; Feces; Hum

1998
Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients.
    Journal of clinical pathology, 1998, Volume: 51, Issue:10

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Antiprotozoal Agents; Drug Combi

1998
[Disseminated infestation of Enterocytozooon bieneusi a an HIV-infected patient].
    Pathologie-biologie, 1999, Volume: 47, Issue:5

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Antiprotozoal Agents; HIV Infect

1999
A preliminary investigation of alternatives to fumagillin for the treatment of Loma salmonae infection in rainbow trout.
    Journal of comparative pathology, 1999, Volume: 121, Issue:3

    Topics: Albendazole; Animals; Antiprotozoal Agents; Cyclohexanes; Fatty Acids, Unsaturated; Fish Diseases; M

1999
Confirmation of transmission of the microsporidian parasite Enterocytozoon bieneusi in South Africa.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2000, Volume: 90, Issue:3

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anti-Bacterial Agents; Antinemat

2000
Chronic diarrhea as a result of intestinal microsposidiosis in a liver transplant recipient.
    Transplantation, 2001, Jan-27, Volume: 71, Issue:2

    Topics: Adult; Albendazole; Animals; Chronic Disease; Diarrhea; Feces; Female; Humans; Intestines; Liver Tra

2001
Microsporidial keratoconjunctivitis in a healthy contact lens wearer without human immunodeficiency virus infection.
    Ophthalmology, 2001, Volume: 108, Issue:5

    Topics: Adult; Albendazole; Animals; Antiprotozoal Agents; Contact Lenses, Hydrophilic; Cornea; Cyclohexanes

2001
PML and a tale of two drug companies.
    Notes from the underground (New York, N.Y.), 1995,Winter, Issue:no 29

    Topics: AIDS-Related Opportunistic Infections; Albendazole; Blood-Brain Barrier; Camptothecin; Drug Industry

1995
Don't get caught with your pants down.
    Notes from the underground (New York, N.Y.), 1996, Issue:no 31

    Topics: AIDS-Related Opportunistic Infections; Albendazole; Anthelmintics; Humans; Intestinal Diseases, Para

1996
Dual microsporidial infection with Encephalitozoon cuniculi and Enterocytozoon bieneusi in an HIV-positive patient.
    Infection, 2001, Volume: 29, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Animals, Domestic; Antiprotozoal

2001
Microsporidial keratoconjunctivitis after HAART.
    Clinical & experimental ophthalmology, 2001, Volume: 29, Issue:5

    Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Antiprotozoal Agents; Antiretrov

2001
Microsporidial endophthalmitis in a patient with acute myelogenous leukemia.
    Retina (Philadelphia, Pa.), 2002, Volume: 22, Issue:1

    Topics: Albendazole; Animals; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Endophth

2002
Microsporidia-induced sclerouveitis with retinal detachment.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:6

    Topics: Aged; Albendazole; Animals; Antiprotozoal Agents; Eye Infections, Parasitic; Female; Humans; Intraoc

2002
Treatment of intestinal microsporidiosis with albendazole in patients with AIDS.
    AIDS (London, England), 1992, Volume: 6, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Albendazole; Animals; Diarrhea; Humans; Male; Microsporid

1992